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Changes in the SC 2007 List of
Reportable Conditions
Libby Greene, MSN, APRN, BC
Director – Surveillance Section/Nurse Consultant
Division of Acute Disease Epidemiology
As authorized by South Carolina Statute #44-20-10 and
Regulation #61-20, the S.C. Department of Health and
Environmental Control (DHEC) updates the list of
Reportable Conditions in January of each year.  Revisions
to the list of reportable conditions are based on many
factors, including: 1) the need for DHEC to conduct
surveillance on new conditions or to increase surveillance
on certain existing conditions in order to protect the health
of the public and 2) changes in reporting requirements
from the Centers for Disease Control and Prevention
(CDC).
The following revisions have been made to the 2007 List
of Reportable Conditions:
Deletions from the list:
• Kawasaki disease
        Revisions:
• For Immediately and Urgently
Reportable Conditions, the following
statement has been added:  “All
suspected and confirmed cases,
including preliminary clinical and
laboratory results.”
• Toxins has been moved from a separate
condition under Urgently Reportable
Conditions and is now included in “Any
Potential Biological, Chemical, or
Terrorist Event” under the Immediately
Reportable Conditions.
• The specific names of the organisms
have been added to Glanders, Q fever,
and Typhus.
• Enterohemorrhagic E. coli is now listed
as “E. coli, shiga toxin-producing
(STEC), including O157:H7”.
• The following statement in footnote #2
regarding HIV reporting has been
deleted: “However, if a confirmation test
Important Dates When Reporting
Diseases
Amy E. Belflower, MSPH
Surveillance and Quality Assurance Epidemiologist
Division of Acute Disease Epidemiology
The South Carolina Department of Health and
Environmental Control (SC DHEC) asks for many types of
information on notifiable disease reports, such as name,
address, disease/condition, and county - just to name a
few.  This demographic information is
important for public health disease
surveillance, investigation, response,
and prevention.  However, an
important component of these reports
is often missing.   Under “What to
Report” on the S.C. List of Reportable
Conditions, “date of onset of disease
and date of report” are listed as
required reporting components.  Not
only is this information required on
disease reports, it is very important for
public health investigations and
disease tracking.  For example,
without information on disease onset
or diagnosis date, it is difficult to
determine if a case may be part of a
temporal cluster of a specific disease.
Additionally, onset dates are often
used as a time indicator on “epi
curves”, which are used to show the
relationship that cases have to one
another during an outbreak
investigation.  Knowing disease onset
dates and the incubation period of the
disease can help public health
investigators determine possible
exposure times.
An analysis of all reportable disease
cases reported to DHEC in 2005
shows that only 18.8 percent of reports
submitted contained onset date and
only 41.0 percent of reports contained
a diagnosis date.  These numbers probably overestimate
the percentage of actual disease reports that included
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is performed within 14 days and is
negative, reactive EIAs alone should not
be reported.”  For 2007, HIV or AIDS
should be reported when serum, urine,
or oral fluid specimen is positive by:  (a)
screening test (e.g., EIA antibody), or (b)
confirmatory test (e.g., Western Blot), or
(c) an HIV detection test (e.g., PCR
nucleic acid test, including viral load), or
(d) clinical diagnosis of a case of HIV or
AIDS.  In addition, all HIV viral load and
CD4 test results must be reported by
laboratories regardless of results.
Also, on the Web site and on the poster, please note the
addresses and phone numbers of the regional public
health departments - several of the addresses and phone
numbers have changed.
The above changes may be found:
       •      In this edition of the Epi Notes
       •      On the DHEC Web site at:
http://www.scdhec.gov/health/disease/index.htm
or
http://www.scdhec.gov/health/disease/docs/
reportable_conditions.pdf
• On the 2007 DHEC Disease Reporting Card
(color is blue for 2007)
• On the 2007 List of Reportable Conditions poster.
Both the Disease Reporting Cards and the
laminated posters (sizes 8 by 11 inches and 12
by 24 inches) are available from the DHEC
regional public health departments or from the
DHEC Division of Acute Disease Epidemiology
in Columbia.
(IMPORTANT DATES WHEN REPORTING DISEASES
cont'd from Page 1)
these two dates.  For many diseases, investigations are
conducted whereby diagnosis and onset dates are
obtained, not only through disease report information, but
also through interviewing patients or from chart reviews.
However, in other cases, diseases are not thoroughly
investigated by public health staff even though tracking
and monitoring of disease trends remains important.
Public health professionals monitor changes in disease
prevalence and demographic characteristics over time to
access prevention/educational efforts for many diseases.
Reporting of onset or diagnosis date by the provider is
sometimes the only means by which this information is
captured and therefore analyzed.  If a disease onset date
is not known, reporting of a diagnosis date may still be a
good proxy indicator of onset date and should be reported
on all disease reports.
Consistent and complete reporting of onset and diagnosis
dates for all disease reports is always pertinent for public
health disease monitoring and investigations.  South
Carolina Law requires reporting of diseases and
conditions listed on the S.C. List of Reportable Conditions
to local public health departments (State Law #44-29-10,
Regulation #61-20, State Laws #44-1-110 and 44-1-140).
Furthermore, cases are to be reported in the manner
designated by DHEC.  DHEC asks that providers report
diagnosis and disease onset dates, if known, on all
reportable condition disease reports.  Your cooperation
on including these dates on reports will greatly benefit our
ability to continue to effectively monitor, investigate, and
prevent acute disease in South Carolina.
Changes in HIV Test Reporting
Lynda Kettinger, MPH
Directior, Division of STD/HIV
All reactive rapid HIV test results must be reported to the
S.C. DHEC HIV Surveillance Program.  Previously, if a
confirmation test was performed within 14 days of a
reactive rapid test and was negative, reactive rapid HIV
tests were not reportable.  With the expected increased
use of rapid tests to screen for HIV, reporting of all reactive
rapid tests, regardless of whether a confirmation test is
done, will help to ensure the completeness of reporting.
This will assist in public health efforts to prevent HIV
infection and in obtaining essential federal HIV care
funding.  Beginning in 2007, Ryan White CARE Act funding
allocations to states will be based on HIV infection cases
in addition to AIDS cases.
Physicians, clinics, laboratories, community organizations,
or any facility that conducts rapid HIV tests may report
reactive results to DHEC using the 1129 Disease Report
Card (indicate ‘Reactive Rapid Test’ in the Specific
Laboratory Results block of the card).  Reporters may also
use the toll-free HIV/AIDS Surveillance Report Line at 1-
800-277-0873, or call (803) 898-0758 in Columbia.
Update for Reporting Meningococcal Disease
Dixie F. Roberts, MPH, APRN
Division Director
Division of Acute Disease Epidemiology
Meningococcal disease most commonly occurs as
meningitis and/or meningococcemia that may progress
rapidly to purpura fulminans, shock, and death. Other
clinical manifestations may occur. Cases are immediately
reportable by phone to the Health Department, as
described on the 2007 List of Reportable Conditions.  To
assure an appropriate and rapid public health response
and contact investigation, confirmed, probable, and
suspect cases of meningococcal disease should be
immediately reported by phone to DHEC.  Do not wait for
culture results to report suspect or probable cases.  In the
S.C. 2007 List of Reportable Conditions, a new footnote
number nine (9) has been added to remind laboratories
that gram stains positive for gram-negative diplococci are
reportable to DHEC as suspects for Meningococcal
disease. The List of Reportable Conditions does not define
all possible clinical and laboratory information needed to
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define confirmed or suspect cases.   The CDC Case
Definitions for Surveillance can be found at the following
web site:
http://www.cdc.gov/epo/dphsi/casedef
meningococcalcurrent.htm
One source for more information on case definitions may
be found in the American Academy of Pediatrics, 2006
Red Book, 27th Edition, Report of the Committee on
Infectious Diseases.
The CDC case definitions for Meningococcal disease are
listed below, all of which should be reported to DHEC.
Suspect:
· Clinical purpura fulminans in the absence of a
positive blood culture
· A clinically compatible case with gram negative
diplococci from a normally sterile site (e.g., blood
or CSF)
Probable:  A clinically compatible case that has either:
· Evidence of N. meningitidis DNA using a validated
polymerase chain reaction (PCR), obtained from
a normally sterile site (e.g,. blood or CSF) ,    OR
· Evidence of N. meningitidis antigen by
immunohistochemistry (IHC) on formalin-fixed
tissue or latex agglutination of CSF
Confirmed:
· A clinically compatible case AND isolation of
Neisseria meningitidis from a normally sterile site
(e.g., blood or cerebrospinal fluid {CSF} or, less
commonly, synovial, pleural, or pericardial fluid)
or skin scrapings of purpuric lesions.
A sputum culture, positive for N. meningitidis, is not from a
sterile site and may simply be an indication of
nasopharyngeal colonization.  Clinical information is
needed to determine if the patient has pneumonia.  Also,
the presence of heavy growth on the culture and numerous
colonies visible on the gram stain are useful lab results
when reporting suspected meningococcal pneumonia.
Revised E. coli Reporting Requirement
Julie Schlegel, MSP
Foodborne Epidemiologist
Division of Acute Disease Epidemiology
Beginning in 2007, the nomenclature for reportable
Escherichia coli will change to reflect the wording used in
the Nationally Notifiable Infectious Diseases List and
specify Shiga toxin-producing E. coli (STEC). All Shiga
toxin-producing E. coli, including O157:H7, must be
reported to the regional public health office by phone within
24 hours.
A clinical case of Shiga toxin-producing E. coli can be
described as an infection of variable severity characterized
by diarrhea (often bloody) and abdominal cramps. Illness
may be complicated by hemolytic uremic syndrome (HUS)
or thrombotic thrombocytopenic purpura (TTP);
asymptomatic infections also may occur and the organism
may cause extraintestinal infections. Laboratory criteria
for a Shiga toxin- producing E. coli case include isolation
of Shiga toxin-producing Escherichia coli from a clinical
specimen.  Escherichia coli O157:H7 isolates may be
assumed to be Shiga toxin-producing.  For all other E. coli
isolates, Shiga toxin production or the presence of Shiga
toxin genes must be determined in order for STEC to be
considered.
Hemolytic Uremic Syndrome
Shirley Jankelevich, MD, MPH
Medical Epidemiologist
Division of Acute Disease Epidemiology
Hemolytic–uremic syndrome (HUS) is a disease
characterized by acute renal failure, microangiopathic
hemolytic anemia, and thrombocytopenia.   HUS occurs
most frequently in young children (under the age of five
years) but may be seen in adolescents and adults.  HUS
is the most common cause of acute renal failure in children.
Cases of HUS may be sporadic or may be associated
with large outbreaks.  Approximately 73,000 cases of HUS
occur annually in the United States; death occurs in 3-5
percent of those affected.
HUS most often follows a prodromal infectious disease,
usually diarrhea caused by a Shiga toxin-producing
bacteria, such as the enterohemorrhagic Escherichia coli
(EHEC) and some strains of Shigella dysenteriae.
However, HUS has also been associated with infections
with other bacteria such as Streptococcus pneumoniae
and Clostridium difficile as well as viruses such as
varicella, echovirus, and coxsackie A and B. It has also
been associated with AIDS, cancer, and the administration
of specific chemotherapeutic agents.
The most common EHEC strain that causes HUS is
serotype O157:H7.  However, HUS has also occurred
following infections caused by strains belonging to
serogroups other than O157, such as O26, O45, O91,
O103, O111, O128, and O145.  All EHEC strains are of
zoonotic origin, with cattle and other ruminants being
recognized as the major reservoir for human infections.
Transmission of EHEC strains occurs by ingestion of food
or water contaminated with these organisms,
contamination of hands with these strains after contact
with colonized animals or their feces, or direct person-to-
person contact.
HUS, with or without gastroenteritis (triad of acute renal
failure, thrombocytopenia, and microangiopathic hemolytic
anemia) is a condition that is urgently reportable by phone
within 24 hours to S.C. DHEC.
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New Reporting Guidelines for Toxins
Amy E. Belflower, MSPH
Surveillance and Quality Assurance Epidemiologist
Division of Acute Disease Epidemiology
Toxins are reportable in South Carolina due to the potential
for toxins to cause outbreaks of disease or possibly be
used as an agent of bioterrorism.  Epsilon toxin of
Clostridium perfringens, ricin toxin, and staphylococcal
enterotoxin B specifically are classified as Category B
agents.  According to the Centers for Disease Control
(CDC), Category B agents are, “moderately easy to
disseminate, result in moderate morbidity rates and low
mortality rates, and require specific enhancements of
CDC’s diagnostic capacity and enhanced disease
surveillance.”
Until 2007, all cases of toxins were urgently reportable
within 24 hours by phone to DHEC.  In 2007, the Toxin
category has been removed from the Urgently Reportable
list and is now included in list of Immediately Reportable
Conditions in the category of “Any potential biological (to
include toxins such as ricin), chemical, or terrorist event”.
Therefore, all suspected cases of biological toxins should
now be reported immediately by phone to local public
health departments.
The decision to move toxins on the List of Reportable
Conditions was made in order to make reporting easier
and clearer regarding the reporting of toxins and possible
clusters of toxin cases.  Any case associated with an event
that is possibly due to toxins should be reported
immediately by phone to the local public health office. Due
to the possible implications and public health
consequences of a marine toxin or ricin exposure, even
one suspected case should be reported immediately.
Single foodborne toxin cases are less threatening to public
health, but should be reported immediately if suspected
to be part of a cluster of cases.  Patients with these toxin
illnesses are not contagious; however, reporting of these
cases is very important.  Through a report, public health
departments can investigate to determine if a restaurant
or a common public food source is implicated or if an
oyster bed or fishing area has a problem, which is
imperative for preventing further illness in the community.
Marine Toxins
Marine toxins are naturally occurring chemicals that can
contaminate certain seafood. The seafood contaminated
with these chemicals frequently looks, smells, and tastes
normal. When humans eat such seafood, disease can
result. The most common diseases caused by marine
toxins in United States in order of incidence are
scombrotoxic fish poisoning, ciguatera poisoning, paralytic
shellfish poisoning, neurotoxic shellfish poisoning, and
amnesic shellfish poisoning.  Due to the geographical
location of South Carolina along the Atlantic coast, cases
of illness with marine toxins occur frequently in South
Carolina and are an important public health issue.
Diagnosis of marine toxin poisoning is generally based
on symptoms and a history of recently eating a particular
kind of seafood. Laboratory testing for the specific toxin in
patient samples is generally not necessary because this
requires special techniques and equipment available in
only specialized laboratories. If suspect leftover fish or
shellfish are available, they can be tested for the presence
of the toxin more easily. Identification of the specific toxin
is not usually necessary for treating patients because there
is no specific treatment.  Every year, approximately 30
cases of poisoning by marine toxins are reported in the
United States; almost 20 outbreaks related to
scrombrotoxic fish poisoning were documented nationally.
Because healthcare providers are not required to report
these illnesses and because many milder cases are not
diagnosed or reported, the actual number of poisonings
may be much greater. Toxic seafood poisonings are more
common in the summer than winter because
dinoflagelates grow well in warmer seasons. It is
estimated from cases with available data that one person
dies every four years from toxic seafood poisonings.
Two cases of ciguatera fish poisoning, in a husband and
wife, were reported to the DHEC in August 2004; the cases
were associated with a barracuda caught approximately
60 miles southeast of Charleston, South Carolina.  These
are the first known cases of ciguatera fish poisoning
caused by fish caught off South Carolina.   This report has
been documented in the September 1, 2006 issue of the
MMWR as well as the Spring 2006 issue of Epi-Notes.
Foodborne Toxins
Staphylococcus aureus, Clostridium perfringens, and
Bacillus cereus are three bacteria that can produce
enterotoxins that cause human gastrointestinal illness.
Illness is caused by eating foods contaminated with toxins
produced by these bacteria.  As the germs multiply in food,
they produce toxins that can cause illness. These toxins
are resistant to heat and cannot be destroyed by cooking.
The most common way for food to be contaminated with
Staphylococcus is through contact with food workers who
carry the bacteria or through contaminated milk and
cheeses. Common vehicles for Clostridium perfringens
are beef, poultry, gravies, and dried or precooked foods.
Bacillus cereus is often found in rice, meat, and vegetables.
Staphylococcal toxins and emetic Bacillus cereus are fast
acting, sometimes causing illness in as little as 30
minutes with symptoms usually developing within 1-6
hours after eating contaminated food, while Clostridium
Proper testing for the EHEC bacteria is of great importance.
New recommendations for appropriate laboratory testing
for EHEC have recently been published (Importance of
Culture Confirmation of Shiga Toxin-producing Escherichia
coli Infection as Illustrated by Outbreaks of Gastroenteritis,
New York and North Carolina, 2005) and can be found at
the CDC Web site: http://www.cdc.gov/mmwr/preview/
mmwrhtml/mm5538a3.htm.
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perfringens and diarrheal Bacillus cereus have a longer
incubation period of 6-24 hours.  Symptoms include nausea
and vomiting (staphylococcal and emetic Bacillus cereus
only), stomach cramps, and diarrhea; the illness is usually
mild and most patients recover after one to three days.  In
a small minority of patients the illness may be more severe.
Toxin-producing organisms can be identified in stool or
vomit, and toxin can be detected in food items. Diagnosis
of toxin-related food poisoning in an individual is generally
based only on the signs and symptoms of the patient.
Testing for the toxin-producing bacteria or the toxin is not
usually done in individual patients. Testing is usually
reserved for outbreaks involving several persons.  Because
healthcare providers are not required to report these
illnesses in all states and because many milder cases
are not diagnosed or reported, the actual number of
poisonings is not known. However, over 20 outbreaks
related to Clostridium perfringens were documented
nationally in 2005.
Ricin
Characteristics:  Ricin is a poison that can be made from
the waste left over from processing castor beans.  It can
be in the form of a powder, a mist, or a pellet, or it can be
dissolved in water or weak acid.  It would take a deliberate
act to make ricin and use it to poison people.  Accidental
exposure to ricin is highly unlikely.  People can breathe in
ricin mist or powder and be poisoned.  Ricin can also get
into water or food and then be swallowed.  Pellets of ricin,
or ricin dissolved in a liquid, can be injected into people’s
bodies.  The major symptoms of ricin poisoning depend
on the route of exposure and the dose received, though
many organs may be affected in severe cases.  Initial
symptoms of ricin poisoning by inhalation may occur within
eight hours of exposure. Following ingestion of ricin, initial
symptoms typically occur in less than six hours.  If it is
suspected that people have inhaled ricin, a potential clue
would be that a large number of people who had been
close to each other suddenly developed fever, cough, and
excess fluid in their lungs. These symptoms could be
followed by severe breathing problems and possibly death.
No widely available, reliable test exists to confirm that a
person has been exposed to ricin.
How to Report Potential Cases of
Botulism
Julie Schlegel, MSP
Foodborne Epidemiologist
Division of Acute Disease Epidemiology
Botulism is a reportable disease that can result from the
improper storage or packaging of food. However,
botulinum toxin is also a potential agent of bioterrorism.
The ingestion of botulinum toxin results in an illness of
variable severity. Common symptoms are diplopia, blurred
vision, and bulbar weakness.  Symmetric paralysis may
progress rapidly. Outbreaks of foodborne botulism have
the potential to be a public health emergency because the
contaminated food may be consumed by many people.
A suspected case of botulism must be reported to the
regional public health office immediately by phone.  When
S.C. DHEC is notified of a potential case of botulism that
meets the case definition, DHEC will contact the Centers
for Disease Control and Prevention (CDC) for consultation.
The CDC can only provide testing of clinical specimens
and food samples if cases are referred from DHEC.
Revised Cholera and Other Vibrio Illness
Reporting Requirement
Julie Schlegel, MSP
Foodborne Epidemiologist
Division of Acute Disease Epidemiology
Beginning in 2007, the nomenclature for cholera and other
Vibrio illness will be clarified to better differentiate between
the toxigenic (i.e., cholera toxin-producing) strains of Vibrio
cholerae and other strains of Vibrio cholerae, which do
not cause cholera-like illness.
Only Vibrio cholerae serogroups O1 and O139 are
associated with the epidemiological characteristics and
clinical picture of cholera.  Illnesses caused by strains of
V. cholerae other than toxigenic V. cholerae O1 or O139
should not be reported as cases of cholera.
Cases with suspected cholera-like illness must be
reported to the regional public health office by phone within
24 hours. Cases with other serogroups of V. cholerae as
well as other species of Vibrio illness should be reported
within seven days to DHEC.
Seasonal Influenza Surveillance and
Reporting 2006-07
Lena M. Bretous MD, MPH
SC Influenza Surveillance Coordinator
Division of Acute Disease Epidemiology
This article provides the healthcare professional with the
latest information on:
· Enhanced avian influenza surveillance
· Recommended laboratory testing
· Voluntary influenza monitoring system networks with
incentives
· Personal behavioral risk reduction methods.
Enhanced Avian Influenza A (H5N1) Surveillance
Effective surveillance for avian influenza in humans will
continue to depend on health care providers consistently
obtaining information regarding international travel and
other exposure risks from persons with specified
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respiratory symptoms as detailed in the recommendations
below. This guidance will be updated as the epidemiology
of H5N1 virus changes.  There have been no significant
changes in the epidemiology of H5N1 since February 2004.
Please visit the World Health Organization (WHO) Web
site for updated information on confirmed human cases
of H5N1 worldwide.  The reference is listed below.
Laboratory testing for avian influenza A (H5N1) virus
infection is recommended for:
A. A patient who has an illness that:
1. Requires hospitalization or is fatal; AND
2. Has or had a documented temperature of
e”38°C (e”100.4 degrees Fahrenheit); AND
3. Has radiographically confirmed pneumonia,
acute respiratory distress syndrome (ARDS),
or other severe respiratory illness for which
an alternate diagnosis has not been establis
B. AND has at least one of the following potential
exposure criteria within 10 days of symptom onset:
1. History of travel to a country with influenza
H5N1 documented in poultry, wild birds, and
or   humans, AND had at least one of the
following potential exposures during travel:
· Direct contact with poultry;
· Direct contact with surfaces
contaminated with poultry feces;
· Consumption of raw or
incompletely cooked poultry
or poultry products;
· Close contact (approach within
1 meter [approximately 3 feet])
of a person who was
hospitalized or died due to a
severe unexplained respiratory
illness;
2. Close contact (approach within 1 meter
[approximately 3 feet]) of an ill patient who
was confirmed or suspected to have H5N1;
3. Worked with live influenza H5N1 virus in a
laboratory.
 
Laboratory Testing for H5N1 virus infection can be
considered on a case-by-case basis, in consultation with
local and state public health departments, for:
· A patient with mild or atypical disease
(hospitalized or ambulatory) who has one of the
exposures listed above (criteria 1, 2, or 3); OR
· A patient with severe or fatal respiratory disease
whose epidemiological information is uncertain,
unavailable, or otherwise suspicious but does
not meet the criteria above (examples include: a
returned traveler from an influenza H5N1-affected
country whose exposures are unclear or
suspicious, a person who had contact with poultry,
etc.)
 Clinicians should contact their local or state public health
department as soon as possible to report any suspected
human case of influenza H5N1 in the United States.  The
CDC and DHEC will provide the most updated specimen
collection guidelines for suspected H5N1 in humans.
DHEC Preferred Influenza Laboratory Testing Practices
for Seasonal Influenza
Serological Influenza Testing is NOT Recommended for
Surveillance Purposes
Routine serological testing for influenza requires paired
acute and convalescent sera, does not provide results to
help with clinical decision-making, and is not generally
recommended. Serological testing results for human
influenza on a single serum specimen is not interpretable
and is not recommended. 
Positive Rapid Antigen Testing and Reporting to DHEC
Commercial rapid diagnostic test kits most commonly use
a nasopharyngeal (NP) swab specimen. Results are
completed in the office in approximately 30 minutes and
indicate the presence of influenza virus as well as
serological typing of A, B, or A and B, depending on the
brand of rapid antigen testing kit used.  Some of these kits
are approved for use in any outpatient setting.  DHEC
requires weekly submission summary numbers of positive
rapid influenza test worksheets by fax or email at the end
of every week (Monday by noon) to the local public health
department.   Those wishing to email this information
weekly should call their local public health department to
make arrangements.
Positive Influenza Culture Testing and Reporting to DHEC
The collection of some respiratory samples for viral culture
is essential for determining the influenza A subtypes and
influenza A and B strains causing il lness and for
surveillance of new strains that may need to be included
in the next year’s influenza vaccine. During outbreaks of
influenza-like illness, viral cultures also can help identify
other causes of illness.
Volunteer Influenza Monitoring Networks to Identify
‘Where, How Much and What Strain’
DHEC Laboratory Influenza Culture Network
As always, DHEC will continue to provide FREE influenza
culture media and pre-paid packaging to practices wishing
to participate in the DHEC Laboratory Influenza Culture
Network.  Providers are asked to submit samples (three
to four) of cultures to DHEC in pre-paid packaging in the
beginning, middle, and end of the season for confirmation
of influenza strains circulating in the state.  Those wishing
to enroll in the Laboratory Culture Network should contact
Nena Turner in the DHEC Bureau of Laboratories at
(803)896-0819 or the epidemiology section at the local
public health department.
CDC Volunteer Influenza-Like Illness (ILI) Sentinel
Providers Network
Digitized by South Carolina State Library
Volunteer health care providers in South Carolina submit
weekly reports to the CDC of the total number of patients
seen and the subset number of those patients with
influenza-like illness (ILI) by age group.  ILI is defined as
fever (temperature of >100degrees Fahrenheit) plus either
a cough and/or a sore throat in the absence of another
known cause other than influenza. ILI syndromes do not
require the support of a laboratory test.  As a bonus,
volunteer providers will receive FREE personalized weekly
email updates of S.C. flu activity, as well as subscriptions
to the CDC MMWR and Emerging Infectious Disease
Journals.  Those wishing to volunteer in this system should
contact Dr. Lena Bretous at (803) 898-0862, or the
epidemiology section at the local public health department
as listed at the end of this health update.
How To Protect Yourself and Your Patients Against the
Flu
Steps health care providers can take to keep themselves
and others healthy this flu season include:
· Getting their flu shot for the regular flu season;
· Covering coughs with their arm or tissue and
throwing tissue away,
· Staying home from work or school when sick with
cough illness; and
· Washing hands after coughing or touching
respiratory secretions.
Resource Links
WHO Confirmed Human Cases of H5N1
· http://www.who.int/csr/disease/avian_influenza/
en/index.html
CDC Respiratory Hygiene/Cough Etiquette in Healthcare
Settings:
· www.cdc.gov/flu/professionals/infectioncontrol/
resphygiene.htm
CDC Guideline for Isolation Precautions in Hospitals:
· www.cdc.gov/ncidod/hip/ISOLAT/Isolat.htm
DHEC Influenza Surveillance Web site:
· http://www.scdhec.gov/health/disease/acute/
flu.htm
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S.C. 2007 List of Reportable Conditions  
Attention: Health Care Facilities, Physicians, and Laboratories 
South Carolina Law §44-29-10 and Regulation §61-20 require reporting of conditions on this list to the local public health department.   
 
HIPAA: Federal HIPAA legislation allows disclosure of protected health information, without consent of the individual, to public health authorities to 
collect and receive such information for the purpose of preventing or controlling disease.  (HIPAA 45 CFR §164.512)  
  
(L) Only Labs required to report. 
(#) Report only total number of positive results; individual case reporting is not necessary.  
1. Outbreak:  An excess number of cases or syndromes over the expected occurrence of disease within a geographic area or population group.  
2. Report HIV or AIDS when serum, urine, or oral fluid specimen is positive by: (a) screening test (e.g. EIA antibody), or (b) confirmatory test (e.g. Western Blot), or (c) an HIV detection test (e.g., PCR 
nucleic acid test, including viral load) or (d) clinical diagnosis of a case of HIV or AIDS.  All reactive rapid HIV test results must be reported to DHEC.   All HIV viral load and CD4 test results must be 
reported by laboratories regardless of results.   
3. Antibiotic resistant organisms: resistant pneumococcus - MIC > 2µg/ml of penicillin G (or Oxacillin disc zone < 19mm) or resistance to any single drug accepted as effective treatment. The definition of 
resistance may differ between laboratories by test methods used to determine susceptibility. Reports should specify the site from which the isolate was obtained and the drug susceptibility profile.  
4. Invasive disease = isolated from normally sterile site: blood, bone, CSF, joint, pericardial, peritoneal or pleural fluid, necrotizing fasciitis, and cellulitis only if isolate is from a tissue biopsy. Always 
specify site of isolate.  
5. Physicians should report serum lead level >10 µg/dL for children under 6 years of age and > 25 µg/dL for persons 6 years or older. 
6. Labs must report results of all lead tests performed.  This includes lab tests performed in physician offices. 
7. Labs should submit these isolates and positive serologies to the DHEC Bureau of Laboratories for confirmatory testing, serotyping, serogrouping, or genotyping.   
8. Acute meningeal symptoms, fever, CSF pleocytosis, sterile culture.  Consult DHEC in outbreaks to submit specimens to lab for virus identification.  
9. Report Gram-negative diplococci in blood or CSF.  
10. HUS, with or without gastroenteritis:  Triad of acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia. 
 
IMMEDIATELY REPORTABLE BY PHONE REPORT WITHIN 7 DAYS 
All suspected and confirmed cases, including preliminary 
clinical and laboratory results. 
 Any outbreak, unusual disease, or cluster of cases (1)  
 Any potential biological (to include toxins such as ricin), chemical, 
or terrorist event.  
 Animal (mammal) bites 
 Anthrax (7) 
 Botulism  
 Foodborne outbreak – unusual cluster 
 Haemophilus influenzae, type b, invasive disease (4) (7) 
 Measles (rubeola) 
 Meningococcal disease (7) (9) 
 Plague (7) 
 Poliomyelitis 
 SARS – Severe Acute Respiratory Syndrome (7) 
 Smallpox  
 Viral Hemorrhagic Fever  
URGENTLY REPORTABLE 
Within 24 hours by phone 
All suspected and confirmed cases, including preliminary 
clinical and laboratory results. 
 Arboviral Neuroinvasive Disease (acute infection, including acute 
flaccid paralysis, atypical Guillain-Barré Syndrome): Eastern 
Equine Encephalitis (EEE), LaCrosse (LAC), St. Louis 
Encephalitis (SLE), West Nile Virus (WNV) (7) 
 Brucellosis (7) 
 Cholera (Vibrio cholerae type O1 and O139) (7) 
 Diphtheria (7)  
 E. coli, shiga toxin – producing (STEC), including O157:H7 (7) 
 Glanders (Burkholderia mallei) (7) 
 Hantavirus 
 Hemolytic uremic syndrome (HUS) (10) 
 Hepatitis A, acute (IgM Ab + only) 
 Hepatitis B, acute (IgM core Ab + only) 
 Melioidosis (Burkholderia pseudomallei) (7)  
 Mumps 
 Pertussis  
 Q fever (Coxiella burnetii) 
 Rabies (human) 
 Rubella (includes congenital) 
 Staphylococcus aureus, vancomycin-resistant  (VRSA/VISA) 
 Syphilis, primary or secondary (lesion or rash) 
 Syphilis, congenital 
 Trichinosis 
 Tuberculosis (7) 
 Tularemia 
 Typhoid fever (Salmonella typhi) (7) 
 Typhus, epidemic (Rickettsia prowazekii) 
 AIDS (2) 
 Campylobacter enteritis  
 CD4 T-lymphocyte count – all results (L) (2) 
 Chancroid 
 Chlamydia trachomatis, genital site (L) 
 Creutzfeldt-Jakob Disease (Age < 55 years) 
 Cryptosporidiosis 
 Cyclosporiasis 
 Dengue 
 Ehrlichiosis 
 Giardiasis 
 Gonorrhea 
 Haemophilus influenzae, non-type b, invasive disease (4) (7) 
 Hepatitis B, chronic  
 Hepatitis B Surface Antigen + (HBsAg +) with each pregnancy 
 Hepatitis C, D, E 
 HIV-1 or HIV-2 infection (2)  
 HIV quantification / viral load – all results (L) (2) 
 Influenza, positive rapid flu test  (#) 
 Influenza, positive virus culture isolates (L) 
 Influenza, pediatric deaths – age ? 17 years  
 Lead poisoning (5) 
 Lead tests, all (6) (L, includes office tests) 
 Legionellosis   
 Leprosy (Hansen’s Disease) 
 Leptospirosis  
 Listeriosis (7) 
 Lyme disease  
 Lymphogranuloma venereum 
 Malaria 
 Meningitis, aseptic (8) 
 Pesticide poisoning 
 Psittacosis  
 Rocky Mountain Spotted Fever  
 Salmonellosis (7) 
 Shigellosis (7) 
 Streptococcus group A, invasive disease (4)  
 Streptococcus group B, age < 90 days 
 Streptococcus pneumoniae, invasive, (4), (include antibiotic 
resistance patterns) (3) 
 Syphilis, latent or tertiary  
 Syphilis, positive serologic test 
 Tetanus  
 Toxic Shock (specify staphylococcal or streptococcal) 
 Varicella 
 Varicella death 
 Vibrio infections (other than Vibrio cholerae O1 or O139) 
 Yellow Fever 
       Yersiniosis  
 
 Potential agent of bioterrorism 
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S.C. 2007 List of Reportable Conditions  
 
How To Report What To Report 
Submit reports by one of the following methods: 
1. For immediately and urgently reportable conditions (M-F, 9-5): call 
your regional public health office.  See list below. 
2. For immediately reportable conditions (nights, weekends, and 
holidays): call your regional public health office nights/weekend 
phone number (see list below), or the statewide DHEC emergency 
phone number (1-888-847-0902).  
3. For routine reports: call your regional public health office or 
complete the DHEC 1129 Disease Reporting Card and mail in an 
envelope marked confidential to your regional public health office. 
(See list below.) 
4. For HIV and AIDS: report these conditions by calling 1-800-277-
0873 or (803) 898-0758, or by submitting a DHEC 1129 Disease 
Reporting Card or appropriate CDC Case Report Form to:  
  STD/HIV Surveillance Division, Mills/Jarrett Complex,  
  Box 101106, Columbia, SC  29211. 
? Patient’s name 
? Patient’s complete address, phone, date of birth, 
race, sex, county, Social Security Number 
? Physician’s name and phone 
? Name, institution, and phone number of person 
reporting 
? Disease or condition 
? Date of onset of disease and date of report 
? Lab results, specimen site, collection date 
? Status: if pregnant, in daycare, or a food-handler 
 
DHEC may request additional clinical information on 
a Case Report Form. 
 
 
Regional Public Health Offices  
Mail or call reports to the Epidemiology Office in each Public Health Region. 
Region I 
Anderson, Oconee 
220 McGee Road 
Anderson, SC 29625 
Phone: (864) 260-4358 
Fax: (864) 260-5623 
Nights / Weekends: 1-866-298-4442 
 
Abbeville, Edgefield, Greenwood, 
Laurens, McCormick, Saluda 
1736 S. Main Street 
Greenwood, SC 29646 
Phone: 1-888-218-5475 
Fax: (864) 942-3690 
Nights / Weekends: 1-800-420-1915 
 
Region 2 
Greenville, Pickens 
PO Box 2507  
200 University Ridge 
Greenville, SC 29602-2507 
Phone: (864) 282-4139 
Fax: (864) 282-4373 
Nights / Weekends: 1-800-993-1186 
 
Cherokee, Spartanburg, Union 
PO Box 4217 
151 E. Wood Street 
Spartanburg, SC 29305-4217 
Phone: (864) 596-2227, x- 210 
Fax: (864) 596-3443 
Nights / Weekends: 1-800-993-1186 
 
Region 3 
Chester, Lancaster, York 
PO Box 817 
1833 Pageland Highway 
Lancaster, SC 29721 
Phone: (803) 286-9948 
Fax: (803) 286-5418 
Nights / Weekends: 1-866-867-3886 
Region 3 (continued) 
Fairfield, Lexington, Newberry, Richland 
2000 Hampton Street 
Columbia, SC 29204 
Phone: (803) 576-2749 
Fax: (803) 576-2993 
Nights / Weekends:  1-888-554-9915 
 
Region 4 
Clarendon, Kershaw, Lee, Sumter 
PO Box 1628 
105 North Magnolia Street 
Sumter, SC 29150 
Phone: (803) 773-5511 
Fax: (803) 775-9941 
Nights/Weekends: 1-877-831-4647 
 
Chesterfield, Darlington, Dillon, Florence, 
Marlboro, Marion 
145 E. Cheves Street 
Florence, SC 29506 
Phone: (843) 661-4830 
Fax: (843) 661-4859 
Nights / Weekends: (843) 660-8145 
 
Region 5 
Bamberg, Calhoun, Orangeburg 
PO Box 1126 
1550 Carolina Avenue 
Orangeburg, SC 29116 
Phone: (803) 533-7199 
Fax: (803) 533-7134 
Nights / Weekends: (803) 954-8513 
 
Aiken, Allendale, Barnwell 
1680 Richland Avenue, W. Suite 40 
Aiken, SC 29801 
Phone: (803) 642-1618 
Fax: (803) 643-8386 
Nights / Weekends: (803) 827-8668 or  
 1-800-614-1519 
 
Region 6 
Georgetown, Horry, Williamsburg 
2830 Oak Street 
Conway, SC 29526-4560 
Phone: (843) 365-3126, x-138 or x-174 
Fax: (843) 365-3153 
Nights / Weekends: (843) 381-6710 
 
Region 7 
Berkeley, Charleston, Dorchester 
4050 Bridge View Drive, Suite 600 
N. Charleston, SC 29405 
Phone: (843) 746-3806 
Fax: (843) 746-3851 
Nights / Weekends: (843) 219-8470 
 
Region 8 
Beaufort, Colleton, Hampton, Jasper 
219 S. Lemacks Street 
Walterboro, SC 29488 
Phone: (843) 549-1516, x-214 
Fax: (843) 549-6845 
Nights / Weekends:  1-800-614-4698 
 
 
DHEC Bureau of Disease Control 
Division of Acute Disease Epidemiology  
1751 Calhoun Street 
Box 101106 
Columbia, SC  29211 
Phone: (803) 898-0861 
Fax: (803) 898-0897 
Nights / Weekends: 1-888-847-0902 
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2007 SOUTH CAROLINA DEPARTMENT OF HEALTH AND ENVIRONMENTAL CONTROL DISEASE REPORTING CARD 
Disease reporting is required by SC Code of Laws Section 44-29-10, Regulation 61-20, 44-1-110, and 44-1-140. See other side for list of reportable diseases. 
Federal HIPAA legislation allows disclosure of protected health information, without consent of the individual, to public health authorities for the purpose of preventing or controlling disease.  (45 CFR §164.512) 
Patient Name Date of Birth Race  Unk Ethnicity Sex Patient Status 
 
(Last) (First) (Middle) 
 
Month / Day / Year 
 Am. Ind.  Black 
 Asian  White 
 Hispanic  Unk 
 Non-Hispanic 
 Male  Female 
 Not Stated 
 In Childcare  Pregnant 
 Food Handler 
Patient Address / City and Zip Code County  Patient ID or SSN Telephone Numbers 
Specimen Site Disease (Include stage, if appropriate) Criteria for Diagnosis 
 Clinical   Laboratory  
 Both 
Date of Onset 
 Symptoms ___________  
 Diagnosis ___________  
Specific Laboratory Results 
Collection Date 
Hepatitis A Serology Results  
Hepatitis A antibody (Acute IgM anti-HAV)  Pos  Neg  Unk 
Hepatitis C Serology Results 
Hepatitis C – EIA........  Pos  Neg  Unk s/co ratio:  
Hepatitis C – RIBA .....  Pos  Neg  Unk 
Hepatitis C – NAT ......  Pos  Neg  Unk 
Hepatitis C – PCR......  Pos  Neg  Unk 
Hepatitis C – Viral Load     
Hepatitis B Serology Results 
   Pos Neg Unk 
 Hepatitis B surface Antigen (HBsAg)..............    
 Hepatitis B core Antibody IgM (HBcAb-IgM) ..    
 Hepatitis B core Antibody Total (HBcAb)........    
 Hepatitis B surface Antibody (HBsAb)............    
 Hepatitis B e Antigen (HBeAg) .......................    
Hepatitis Diagnosis 
 Hepatitis A.........................  Acute  
 Hepatitis B.........................  Acute  Chronic 
 Hepatitis C ........................  Acute  Chronic 
 Hepatitis Other ___________________________________  
Hepatitis Clinical Information 
 Pregnant:  Yes  No Jaundice:  Yes  No 
 ALT:   Date:   AST:   Date:   
For STD Reporting 
 Pregnant: ................  Yes  No 
 Treated: ..................  Yes  No 
 Rx:  
  
 Treatment planned:  Yes  No 
 Treatment unknown:  Yes   No 
Responsible Physician & Phone # Reporting Lab/Facility, Person, & Phone # Date Reported to Health Dept. 
For daytime & after-hours phone numbers: www.scdhec.gov/health/disease/docs/reportable_conditions.pdf 
For after-hours reporting of immediately reportable conditions, call state answering service: 1-888-847-0902 
For more information, call DHEC Bureau of Disease Control, Columbia: 803-898-0861 (M-F 9-5) 
For DHEC Use Only       (Initial & Date)       County Review Date      State Review Date C    P    S    N 
DHEC 1129 (01/2007) 
 Send More Cards To: 
 (Address) 
Mail or Call Reports To: 
 
Reporting required by attending physician/designee and laboratory except where lab only (L) reporting is indicated. 
Report IMMEDIATELY By Phone Urgently Reportable Within 24 Hours By Phone 
 Any outbreak or unusual disease or 
 cluster of cases.   
 Any potential  biological (to include 
toxins such as ricin), chemical, or 
terrorist event (1) 
 Animal (mammal) bites 
 Anthrax (7) 
 Botulism 
 Foodborne outbreak – unusual cluster 
 Haemophilus influenzae type b, 
invasive disease (4) (7) 
 Measles (Rubeola) 
 Meningococcal disease (7) (9) 
 Plague (7) 
 Poliomyelitis 
 SARS, Severe Acute Respiratory 
Syndrome   
 Smallpox 
 Viral Hemorrhagic Fever  
 Arboviral Neuroinvasive Disease (acute infection, 
including acute flaccid paralysis, atypical Guillain- 
Barré Syndrome): Eastern Equine Encephalitis 
(EEE), LaCrosse (LAC), St. Louis Encephalitis 
(SLE), West Nile Virus (WNV) (7) 
 Brucellosis (7) 
 Cholera (Vibrio cholerae) type O1 and O139 (7) 
 Diphtheria (7) 
 E-coli, shiga toxin-producing (STEC), including 
O157:H7 (7) 
 Glanders (Burkholderia mallei) (7) 
 Hantavirus 
 Hemolytic uremic syndrome  (HUS) 
 Hepatitis A, acute (IgM Ab+ only) 
 Hepatitis B, acute (IgM core+) 
 Melioidosis (Burkholderia pseudomallei) (7) 
 Mumps 
 Pertussis 
 Q fever (Coxiella burnetti) 
 Rabies (human) 
 Rubella (includes congenital) 
 Staphylococcus aureus, vancomycin-resistant 
(VRSA/VISA) 
 Syphilis, primary or secondary (lesion or rash)  
 Syphilis, congenital 
 Trichinosis 
 Tuberculosis (7) 
 Tularemia 
 Typhoid fever (Salmonella typhi) (7) 
 Typhus fever, epidemic (Richettsia prowazekii) 
Report Within 7 Days 
AIDS (2) 
Campylobacter enteritis 
CD4 T-lymphocyte count – all results (L) (2) 
Chancroid 
Chlamydia trachomatis, genital site (L) 
Creutzfeldt-Jakob Disease (Age < 55 years) 
Cryptosporidiosis 
Cyclosporiasis 
Dengue 
Ehrlichiosis 
Giardiasis 
Gonorrhea  
Haemophilus influenzae, non-type b invasive disease (4)(7) 
Hepatitis B, chronic 
Hepatitis B Surface Antigen+ (HBsAg+) with each pregnancy 
Hepatitis C, D, E 
HIV-1 or HIV-2 infection (2) 
HIV quantification / viral load – all results (L) (2) 
Influenza, positive rapid flu test (report # of positive results) 
Influenza, positive virus culture isolates (L) 
Influenza, pediatric deaths – age ? 17 years 
Lead poisoning (5) 
Lead tests, all (6) (L, includes office tests) 
Legionellosis  
Leprosy (Hansen’s Disease) 
Leptospirosis 
 Listeriosis (7) 
 Lyme disease  
 Lymphogranuloma venereum 
 Malaria 
 Meningitis, aseptic (8) 
 Pesticide poisoning 
 Psittacosis 
 Rocky Mountain Spotted Fever  
 Salmonellosis (7) 
 Shigellosis (7) 
 Streptococcus group A, invasive disease (4) 
 Streptococcus group B, age < 90 days 
Streptococcus pneumoniae, invasive, (4) (include 
antibiotic resistance patterns) (3) 
Syphilis, latent or tertiary  
Syphilis, positive serologic test 
Tetanus 
Toxic Shock (specify staphylococcal or streptococcal) 
Varicella 
Varicella death 
Vibrio infections (other than Vibrio cholerae O1 or 
O139) 
Yellow Fever 
Yersiniosis  
 Potential agent of Bioterrorism (L) Only labs required to report.  For notes 1–10, see complete list of reportable diseases at: www.scdhec.gov/health/disease/docs/reportable_conditions.pdf. 
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Year-to-Date Summary of Selected Reportable Conditions - January 1, 2006 - August 14, 2006 *
C o n d i t io n  C o n f i r m e d  P r o b a b le  T o ta l  
A n th ra x  0  *  0  
A rb o v ira l N e u ro in v a s iv e  D is e a s e  0  0  0  
B o tu lis m  0  0  0  
B ru c e l lo s is  2  0  2  
C a m p y lo b a c te r  e n te r id it is  1 8 3  0  1 8 3  
C h o le ra  0  *  0  
C re u tz fe ld t -J a k o b  d is e a s e  (a g e  < 5 5  y e a rs )  0  0  0  
C ry p to s p o r id io s is  1 2 1  *  1 2 1  
C y c lo s p o r ia s is  4  *  4  
D e n g u e  0  1  1  
D ip h th e r ia  0  0  0  
E h r lic h io s is  2  5  7  
E n te ro h e m o rrh a g ic  E . C o l i ( in c lu d e s  O 1 5 7 :H 7 )  6  0  6  
G ia rd ia s is  8 9  1  8 9  
G la n d e rs  0  0  0  
H a e m o p h iliu s  in f lu e n z a e , n o n - ty p e  b  in v a s iv e  d is e a s e  2 6  0  2 6  
H a e m o p h ilu s  in f lu e n z a e  ty p e  b ,  in v a s iv e  d is e a s e  2  0  2  
H a n ta v i ru s  0  *  0  
H e m o ly t ic  u re m ic  s y n d ro m e  2  0  2  
H e p a t it is  A , a c u te  2 4  *  2 4  
H e p a t it is  B , a c u te  8 1  *  8 1  
H e p a t it is  B , c h ro n ic  5 3 2  *  5 3 2  
H e p a t it is  C , a c u te  0  *  0  
H e p a t it is  C , c h ro n ic  o r  p a s t 2 ,5 1 8  1 ,4 6 4  3 ,9 8 2  
H e p a t it is  D  1  *  1  
H e p a t it is  E  1  *  1  
In f lu e n z a ,  p o s it iv e  v iru s  c u lt u re  is o la te s  3 0  *  3 0  
K a w a s a k i  d is e a s e  3  *  3  
L e g io n e l lo s is  5  *  5  
L e p ro s y  0  *  0  
L e p to s p iro s is  0  0  0  
L is te r io s is  9  *  9  
L y m e  d is e a s e  1 8  *  1 8  
M a la r ia  9  *  9  
M e a s le s  ( ru b e o la )  0  0  0  
M e n in g it is ,  a s e p t ic  9 2  *  9 2  
M e n in g o c o c c a l d is e a s e  1 9  0  1 9  
M u m p s  4  0  4  
P e r tu s s is  1 4 6  2 1  1 6 7  
P la g u e  0  0  0  
P o lio m y e l it is  0  0  0  
P s it ta c o s is  0  0  0  
Q  fe v e r  0  0  0  
R a b ie s  (h u m a n )  0  *  0  
R o c k y  M o u n ta in  S p o tte d  F e v e r  2  4 0  4 2  
R u b e l la  ( in c lu d e s  c o n g e n i ta l)  0  0  0  
S a lm o n e llo s is  8 9 0  6  8 9 6  
S A R S  0  0  0  
S h ig e l lo s is  7 7  0  7 7  
S m a llp o x  0  0  0  
S ta p h y lo c o c c u s  a u re u s , v a n c o m y c in - re s is ta n t (V R S A /V IS A )  0  *  0  
S t re p to c o c c u s  g ro u p  A ,  in v a s iv e  d is e a s e  5 7  *  5 7  
S t re p to c o c c u s  g ro u p  B ,  a g e  <  9 0  d a y s  3 0  *  3 0  
S t re p to c o c c u s  p n e u m o n ia e , in v a s iv e  1 8 6  *  1 8 6  
T e ta n u s  1  *  1  
T o x ic  S h o c k  (S ta p h y lo c o c c a l o r  S tre p to c o c c a l )  0  0  0  
T o x in s  1  0  1  
T r ic h in o s is  0  *  0  
T u la re m ia  0  0  0  
T y p h o id  F e v e r  0  0  0  
T y p h u s  (s c ru b )  f e v e r  0  0  0  
V a r ic e lla  5 5 3  4 1 6  9 6 9  
V ib r io  in fe c t io n s  (n o n -c h o le ra )  6  *  6  
V i ra l  H e m o rrh a g ic  F e v e r  0  0  0  
Y e llo w  F e v e r  0  0  0  
Y e rs in io s is  5  0  5  
    
*  P ro b a b le  c a s e  s ta tu s  is  n o t  a llo w e d  fo r  t h is  c o n d it io n .     
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